SCHEMBL17023099

SCHEMBL17023099

COc1cc(OC)c(Cl)c(-c2ccc(OC(=O)Nc3ccc(N(C)CCN(C)C)nc3)c3nccnc23)c1Cl

nearest known ligand 0.79

Predicted protein targets (top 1)

geneUniProtsupporting neighboursconfidence
FGFR3 P22607 20/20 0.79

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL12678246 0.88 FGFR3 (1.00) FGFR3
SCHEMBL17023145 0.84 FGFR3 (0.62) FGFR3
SCHEMBL17023093 0.83 FGFR3 (0.55) FGFR3
SCHEMBL17023169 0.82 FGFR3 (0.54) FGFR3
SCHEMBL17023032 0.81 FGFR3 (0.64) FGFR3
SCHEMBL17023107 0.81 FGFR3 (0.53) FGFR3
SCHEMBL17023040 0.80 FGFR3 (0.55) FGFR3
SCHEMBL17023058 0.80 FGFR3 (0.79) FGFR3
SCHEMBL17023102 0.80 FGFR3 (0.79) FGFR3
SCHEMBL17023014 0.79 FGFR3 (0.54) FGFR3

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-2282995-B1 DERIVATIVES OF QUINOLINES AND QUINOXALINES AS PROTEIN TYROSINE KINASE INHIBITORS NOVARTIS AG (CH) 2015-08-26 EP claimed